GluA4 facilitates cerebellar expansion coding and enables associative memory formation

  1. Katarzyna Kita
  2. Catarina Albergaria
  3. Ana S Machado
  4. Megan R Carey
  5. Martin Mueller
  6. Igor Delvendahl  Is a corresponding author
  1. University of Zurich, Switzerland
  2. Champalimaud Centre for the Unknown, Portugal
  3. Champalimaud Foundation, Portugal

Abstract

AMPA receptors (AMPARs) mediate excitatory neurotransmission in the CNS and their subunit composition determines synaptic efficacy. Whereas AMPAR subunits GluA1–GluA3 have been linked to particular forms of synaptic plasticity and learning, the functional role of GluA4 remains elusive. Here we demonstrate a crucial function of GluA4 for synaptic excitation and associative memory formation in the cerebellum. Notably, GluA4-knockout mice had ~80% reduced mossy fiber to granule cell synaptic transmission. The fidelity of granule cell spike output was markedly decreased despite attenuated tonic inhibition and increased NMDA receptor-mediated transmission. Computational network modeling incorporating these changes revealed that deletion of GluA4 impairs granule cell expansion coding, which is important for pattern separation and associative learning. On a behavioral level, while locomotor coordination was generally spared, GluA4-knockout mice failed to form associative memories during delay eyeblink conditioning. These results demonstrate an essential role for GluA4-containing AMPARs in cerebellar information processing and associative learning.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 1-5; source code for simulations and modeling is available at https://github.com/delvendahl/GluA4_cerebellum_eLife.

Article and author information

Author details

  1. Katarzyna Kita

    Department of Molecular Life Sciences, University of Zurich, Zurich, Switzerland
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8371-7941
  2. Catarina Albergaria

    Champalimaud Neuroscience Programme, Champalimaud Centre for the Unknown, Lisbon, Portugal
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8257-3600
  3. Ana S Machado

    Champalimaud Neuroscience Programme, Champalimaud Centre for the Unknown, Champalimaud Foundation, Lisbon, Portugal
    Competing interests
    No competing interests declared.
  4. Megan R Carey

    Champalimaud Neuroscience Program, Champalimaud Centre for the Unknown, Champalimaud Foundation, Lisbon, Portugal
    Competing interests
    Megan R Carey, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4499-1657
  5. Martin Mueller

    Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1624-6761
  6. Igor Delvendahl

    Department of Molecular Life Sciences, University of Zurich, Zurich, Switzerland
    For correspondence
    igor.delvendahl@uzh.ch
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6151-2363

Funding

European Research Council (640093)

  • Megan R Carey

Portuguese Fundação para a Ciência e a Tecnologia (PTDC/MED-NEU/30890/2017)

  • Megan R Carey

European Research Council (679881)

  • Martin Mueller

Swiss National Science Foundation (PP00P3_144816)

  • Martin Mueller

Swiss National Science Foundation (PZ00P3_174018)

  • Igor Delvendahl

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Solange P Brown, Johns Hopkins University, United States

Ethics

Animal experimentation: This study was performed in strict accordance with national and institutional guidelines. All experiments were approved by the Cantonal Veterinary Office of Zurich (authorization no. ZH206/2016 and ZH009/2020) or by the Portuguese Direcção Geral de Veterinária (Ref. No. 0421/000/000/2015).

Version history

  1. Received: November 24, 2020
  2. Accepted: July 1, 2021
  3. Accepted Manuscript published: July 5, 2021 (version 1)
  4. Version of Record published: July 20, 2021 (version 2)

Copyright

© 2021, Kita et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,689
    Page views
  • 228
    Downloads
  • 9
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Katarzyna Kita
  2. Catarina Albergaria
  3. Ana S Machado
  4. Megan R Carey
  5. Martin Mueller
  6. Igor Delvendahl
(2021)
GluA4 facilitates cerebellar expansion coding and enables associative memory formation
eLife 10:e65152.
https://doi.org/10.7554/eLife.65152

Share this article

https://doi.org/10.7554/eLife.65152

Further reading

    1. Neuroscience
    Kiwamu Kudo, Kamalini G Ranasinghe ... Srikantan S Nagarajan
    Research Article

    Alzheimer’s disease (AD) is characterized by the accumulation of amyloid-β and misfolded tau proteins causing synaptic dysfunction, and progressive neurodegeneration and cognitive decline. Altered neural oscillations have been consistently demonstrated in AD. However, the trajectories of abnormal neural oscillations in AD progression and their relationship to neurodegeneration and cognitive decline are unknown. Here, we deployed robust event-based sequencing models (EBMs) to investigate the trajectories of long-range and local neural synchrony across AD stages, estimated from resting-state magnetoencephalography. The increases in neural synchrony in the delta-theta band and the decreases in the alpha and beta bands showed progressive changes throughout the stages of the EBM. Decreases in alpha and beta band synchrony preceded both neurodegeneration and cognitive decline, indicating that frequency-specific neuronal synchrony abnormalities are early manifestations of AD pathophysiology. The long-range synchrony effects were greater than the local synchrony, indicating a greater sensitivity of connectivity metrics involving multiple regions of the brain. These results demonstrate the evolution of functional neuronal deficits along the sequence of AD progression.

    1. Medicine
    2. Neuroscience
    Luisa Fassi, Shachar Hochman ... Roi Cohen Kadosh
    Research Article

    In recent years, there has been debate about the effectiveness of treatments from different fields, such as neurostimulation, neurofeedback, brain training, and pharmacotherapy. This debate has been fuelled by contradictory and nuanced experimental findings. Notably, the effectiveness of a given treatment is commonly evaluated by comparing the effect of the active treatment versus the placebo on human health and/or behaviour. However, this approach neglects the individual’s subjective experience of the type of treatment she or he received in establishing treatment efficacy. Here, we show that individual differences in subjective treatment - the thought of receiving the active or placebo condition during an experiment - can explain variability in outcomes better than the actual treatment. We analysed four independent datasets (N = 387 participants), including clinical patients and healthy adults from different age groups who were exposed to different neurostimulation treatments (transcranial magnetic stimulation: Studies 1 and 2; transcranial direct current stimulation: Studies 3 and 4). Our findings show that the inclusion of subjective treatment can provide a better model fit either alone or in interaction with objective treatment (defined as the condition to which participants are assigned in the experiment). These results demonstrate the significant contribution of subjective experience in explaining the variability of clinical, cognitive, and behavioural outcomes. We advocate for existing and future studies in clinical and non-clinical research to start accounting for participants’ subjective beliefs and their interplay with objective treatment when assessing the efficacy of treatments. This approach will be crucial in providing a more accurate estimation of the treatment effect and its source, allowing the development of effective and reproducible interventions.